VIVEbiotech Drives Innovation in Lentiviral Vector Purification
Cutting-edge technologies redefining advanced therapy development.
At VIVEbiotech, innovation and scientific excellence are at the heart of our mission. In recent years, our team has focused on developing breakthrough technologies for lentiviral vector purification, surpassing traditional methods based on anion exchange chromatography. With a patent in progress, we remain committed to accelerating development and ensuring therapies reach patients faster and with confidence.
These achievements represent a major step forward in the field and reinforce our position as a leader in tailored solutions for advanced therapies.
馃帴 Watch the full video on our YouTube channel and LinkedIn to learn more about these advances.
馃憠 www.vivebiotech.com | 馃摡 [email protected]